Meridian Bioscience reported $913.3M in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 209.42B 3.44B
Accelerate Diagnostics AXDX:US 0.36B 0.13B
Antares Pharma ATRS:US $ 0.62B 0.12B
Atrion ATRI:US 1.26B 0.12B
Becton, Dickinson and BDX:US $ 70.6B 0.76B
Bio Rad Laboratories BIO:US $ 22.28B 3.12B
Cerulean Pharma CERU:US $ 0.12B 0.02B
Cerus CERS:US $ 1.05B 0.03B
Genmark Diagnostics GNMK:US $ 1.05B 0.04B
Luminex LMNX:US $ 1.51B 0.43B
Meridian Bioscience VIVO:US $ 0.83B 0.13B
Myriad Genetics MYGN:US $ 2.52B 0.16B
Neogen NEOG:US $ 4.67B 0.28B
Orasure Technologies OSUR:US $ 0.81B 0.08B
Oxford Immunotec Global OXFD:US 0.3B 0.03B
Quidel QDEL:US $ 5.88B 0.42B
Rockwell Medical RMTI:US $ 0.06B 0.03B
Sientra SIEN:US $ 0.33B 0.13B
Staar Surgical STAA:US $ 6.09B 1.06B
Thermo Fisher Scientific TMO:US $ 224.77B 26.5B
Trinity Biotech TRIB:US 0.04B 0.02B
Utah Medical Products UTMD:US $ 0.34B 0.02B